drugset / Trial / NCT00231634
A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea Therapy
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the effectiveness and safety of topiramate with placebo in the treatment of obesity and Type 2 diabetes mellitus in patients who have failed on sulfonylurea therapy.
Timeline
- Start
- 2001-05
- Primary completion
- —
- Completion
- 2002-11
Outcome
Outcome not reported
Stopped: “Program discontinued”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 96 mg | Oral |
| Subject | Topiramate | Small molecule | 192 mg | Oral |
| Subject | Topiramate | Small molecule | 256 mg | Oral |